UMB Bank’s Apellis Pharmaceuticals APLS Stock Holding History

UMB Bank’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-194	Closed	-$7.8K	–	2307
2026 Q1	$7.8K	Buy	194 +182	+1,517%	+$3.92K	﹤0.01%	1936
2025 Q4	$301	Buy	+12	New	+$282	﹤0.01%	2265

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UMB Bank's APLS Position: Q2 2026 in Review

UMB Bank sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 194 shares — an estimated $7.8K sold.

UMB Bank first reported a position in APLS in Q4 2025 and held it in 2 quarters. The position peaked at $7.8K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

UMB Bank reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
UMB Bank sold 194 Apellis Pharmaceuticals shares in Q2 2026, an estimated $7.8K.
UMB Bank first reported a position in Apellis Pharmaceuticals in Q4 2025 and held it in 2 quarters.
UMB Bank's Apellis Pharmaceuticals position peaked at $7.8K in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.